Jonas Weyler
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease.
Journal: Cardiovascular diabetology
Published: March 06, 2025
Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes.
Journal: JHEP reports : innovation in hepatology
Published: January 05, 2023
Microbiome-derived ethanol in nonalcoholic fatty liver disease.
Journal: Nature medicine
Published: February 07, 2022
Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome.
Journal: Circulation research
Published: November 23, 2021
Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis.
Journal: Biomedicines
Published: October 28, 2020
A pharmacokinetic study to guide dosing of tenofovir disoproxil fumarate during different modalities of renal replacement therapy.
Journal: Clinical biochemistry
Published: February 12, 2020
Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 12, 2019
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity.
Journal: Frontiers in immunology
Published: October 17, 2018
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease.
Journal: Frontiers in immunology
Published: August 31, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026